China SXT Pharmaceuticals (SXTC) Finished Goods (2023 - 2025)
Historic Finished Goods for China SXT Pharmaceuticals (SXTC) over the last 3 years, with Q1 2025 value amounting to $448668.0.
- China SXT Pharmaceuticals' Finished Goods fell 1896.65% to $448668.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $448668.0, marking a year-over-year decrease of 1896.65%. This contributed to the annual value of $448668.0 for FY2025, which is 1896.65% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Finished Goods of $448668.0 as of Q1 2025, which was down 1896.65% from $553682.0 recorded in Q1 2024.
- China SXT Pharmaceuticals' Finished Goods' 5-year high stood at $553682.0 during Q1 2024, with a 5-year trough of $446866.0 in Q1 2023.
- Over the past 3 years, China SXT Pharmaceuticals' median Finished Goods value was $448668.0 (recorded in 2025), while the average stood at $483072.0.
- In the last 5 years, China SXT Pharmaceuticals' Finished Goods skyrocketed by 2390.34% in 2024 and then crashed by 1896.65% in 2025.
- China SXT Pharmaceuticals' Finished Goods (Quarter) stood at $446866.0 in 2023, then grew by 23.9% to $553682.0 in 2024, then decreased by 18.97% to $448668.0 in 2025.
- Its Finished Goods stands at $448668.0 for Q1 2025, versus $553682.0 for Q1 2024 and $446866.0 for Q1 2023.